{"cluster": 38, "subcluster": 6, "abstract_summ": "During the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102) pandemic, transplant clinicians should be readily informed about new cases of COVID\u201019 pneumonia in solid organ transplant recipients, with focus on therapeutic strategies employed and their outcome.First one is a 59-year old renal transplant recipient; the second is a 51-year old allogeneic bone marrow transplant recipient.Based on this limited data, liver transplant recipients appear to have a low incidence of COVID\u201019, with less severe symptoms than expected, when compared with the general population and other solid organ recipients.We describe the case of a 61\u2010year\u2010old kidney transplant recipient with several comorbidities who was hospitalized and later received a diagnosis of COVID\u201019 pneumonia; the infection was successfully managed with the use of hydroxychloroquine and a single administration of tocilizumab, after immunosuppression reduction; the patient did not require mechanical ventilation.Although immunosuppressed patients may be more prone to SARS\u2010CoV\u20102 infection with atypical presentation, long\u2010term immunosuppression therapy may provide some sort of protection for severe clinical complications of COVID\u201019.", "title_summ": "Successful recovery of COVID\u201019 pneumonia in a renal transplant recipient with long\u2010term immunosuppressionCOVID\u201019 in a High\u2010Risk Dual Heart and Kidney Transplant RecipientSuccessful recovery from severe COVID\u201019 pneumonia after kidney transplantation: The interplay between immunosuppression and novel therapy including tocilizumabVarying presentations of COVID\u201019 in young heart transplant recipients: A case seriesRenal Infarct in a COVID\u201019 Positive Kidney\u2010Pancreas Transplant RecipientCOVID\u201019 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquineLow prevalence and disease severity of COVID\u201019 in post\u2010liver transplant recipients\u2014A single centre experienceCOVID-19 in post-transplantation patients- report of two cases.", "title_abstract_phrases": "First one is a 59-year old renal transplant recipient; the second is a 51-year old allogeneic bone marrow transplant recipient.Further studies are required to determine thromboprophylaxis indications and duration in solid organ transplant recipients with COVID\u201019.COVID\u201019 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquineCoronavirus disease 2019 (COVID\u201019) pneumonia has been poorly reported in solid organ transplanted patients; prognosis is uncertain and best management unclear.Based on this limited data, liver transplant recipients appear to have a low incidence of COVID\u201019, with less severe symptoms than expected, when compared with the general population and other solid organ recipients.We describe the case of a 61\u2010year\u2010old kidney transplant recipient with several comorbidities who was hospitalized and later received a diagnosis of COVID\u201019 pneumonia; the infection was successfully managed with the use of hydroxychloroquine and a single administration of tocilizumab, after immunosuppression reduction; the patient did not require mechanical ventilation.During the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102) pandemic, transplant clinicians should be readily informed about new cases of COVID\u201019 pneumonia in solid organ transplant recipients, with focus on therapeutic strategies employed and their outcome."}